{"nct_id":"NCT05261399","title":"Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment","status":"RECRUITING","status_verified_date":"2025-01","start_date":"2022-08-03","start_date_type":"ACTUAL","primary_completion_date":"2025-06-26","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-17","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}